These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5524897)

  • 1. [Blood sugar depression effects of hydroxytolbutamide in man].
    Schulz E; Schmidt FH
    Klin Wochenschr; 1970 Jun; 48(12):759-60. PubMed ID: 5524897
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recurrent hypoglycemic coma due to abnormal degradation of tolbutamide].
    Schulz E; Brinkmann W
    Dtsch Med Wochenschr; 1968 Mar; 93(11):485-91. PubMed ID: 5638113
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine.
    Thiessen JJ; Rowland M
    J Pharm Sci; 1977 Aug; 66(8):1063-70. PubMed ID: 894490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the action of tolbutamide in normal man. I. Role of adrenergic mechanisms in tolbutamide-induced insulin release during normoglycaemia and induced hypoglycaemia.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):506-18. PubMed ID: 4739358
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological activities of tolbutamide and its metabolites. A dissociation of insulin-releasing and hypoglycemic activity.
    Feldman JM; Lebovitz HE
    Diabetes; 1969 Aug; 18(8):529-37. PubMed ID: 5808747
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mechanism of action of tolbutamide.
    Mahler RJ; Szabo O
    Horm Metab Res; 1970 Jan; 2(1):9-12. PubMed ID: 5520757
    [No Abstract]   [Full Text] [Related]  

  • 7. Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide.
    Baker IA; Jarrett RJ
    Lancet; 1972 Nov; 2(7784):945-7. PubMed ID: 4116824
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic changes induced by intravenous administration of sorbitol to healthy subjects and the effect of tolbutamide and butylbiguanide].
    Brodan V; Kuhn E; Válek J; Slabochová Z; Brodanová M
    Cas Lek Cesk; 1973 May; 112(18):549-55. PubMed ID: 4701731
    [No Abstract]   [Full Text] [Related]  

  • 9. [Response to xylitol infusion in the metabolism of healthy individuals and its influencing by tolbutamide and butylbiguanide].
    Brodan V; Válek J; Slabochová Z; Brodanová M; Kuhn E
    Cas Lek Cesk; 1973 May; 112(18):555-61. PubMed ID: 4701732
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in plasma cortisol, free fatty acids and glucose during tolbutamide-induced hypoglycemia. Further observations.
    Laurian L; Oberman Z; Harell A; Yaskolka H; Herzberg M
    Isr J Med Sci; 1973; 9(11):1585-8. PubMed ID: 4778405
    [No Abstract]   [Full Text] [Related]  

  • 11. Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.
    Robson RA; Miners JO; Whitehead AG; Birkett DJ
    Br J Clin Pharmacol; 1987 Jun; 23(6):772-5. PubMed ID: 3606937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses to intravenous tolbutamide by Nigerians--a preliminary study.
    Adadevoh BK; Bolodeoku JO
    West Afr J Pharmacol Drug Res; 1975 Jun; 2(1):5-9. PubMed ID: 1226732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coefficient of glucose assimilation and blood sugar curves following administration of tolbutamide to patients with chronic hepatitis].
    Ciba T; Sowa J
    Pol Arch Med Wewn; 1974 Nov; 52(5):457-64. PubMed ID: 4427794
    [No Abstract]   [Full Text] [Related]  

  • 14. Occurrence of impaired cortisol regulation in children with hypoglycemia associated with adrenal medullary hyporesponsiveness.
    Tietze HU; Zurbrügg RP; Zuppinger KA; Joss EE; Käser H
    J Clin Endocrinol Metab; 1972 Jun; 34(6):948-58. PubMed ID: 5020424
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of probenecid to inhibit the rate of metabolism of tolbutamide in man.
    Brook R; Schrogie JJ; Solomon HM
    Clin Pharmacol Ther; 1968; 9(3):314-7. PubMed ID: 5649983
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of cyclamate on the hypoglycaemic response of tolbutamide and chlorpropamide in rats.
    Lockwood RR; Dixon RL
    Food Cosmet Toxicol; 1969 Nov; 7(6):565-70. PubMed ID: 5386600
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihyperglycemic effect of onion: effect on fasting blood sugar and induced hyperglycemia in man.
    Sharma KK; Gupta RK; Gupta S; Samuel KC
    Indian J Med Res; 1977 Mar; 65(3):422-9. PubMed ID: 336527
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 19. [The behavior of glucose, pyruvic acid and nonesterified fatty acids following i.v. tolbutamide loading in fatty liver].
    Teichmann W; Bchardt U
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):217-20. PubMed ID: 5732400
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.